Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 4
2005 15
2006 25
2007 16
2008 15
2009 29
2010 29
2011 17
2012 12
2013 4
2014 9
2015 9
2016 11
2017 11
2018 11
2019 8
2020 12
2021 12
2022 15
2023 26
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system.
Resta E, Cuscianna E, Pierucci P, Custodero C, Solfrizzi V, Sabbà C, Palmisano CM, Barratta F, De Candia ML, Tummolo MG, Capozza E, Lomuscio S, De Michele L, Tafuri S, Resta O, Lenato GM. Resta E, et al. Among authors: solfrizzi v. Front Public Health. 2023 Dec 21;11:1273853. doi: 10.3389/fpubh.2023.1273853. eCollection 2023. Front Public Health. 2023. PMID: 38179561 Free PMC article.
The epigenetics of frailty.
Lozupone M, Solfrizzi V, Sardone R, Dibello V, Castellana F, Zupo R, Lampignano L, Bortone I, Daniele A, Panza F. Lozupone M, et al. Among authors: solfrizzi v. Epigenomics. 2024 Feb;16(3):189-202. doi: 10.2217/epi-2023-0279. Epub 2023 Dec 19. Epigenomics. 2024. PMID: 38112012 Review.
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes.
Le Guen Y, Luo G, Ambati A, Damotte V, Jansen I, Yu E, Nicolas A, de Rojas I, Peixoto Leal T, Miyashita A, Bellenguez C, Lian MM, Parveen K, Morizono T, Park H, Grenier-Boley B, Naito T, Küçükali F, Talyansky SD, Yogeshwar SM, Sempere V, Satake W, Alvarez V, Arosio B, Belloy ME, Benussi L, Boland A, Borroni B, Bullido MJ, Caffarra P, Clarimon J, Daniele A, Darling D, Debette S, Deleuze JF, Dichgans M, Dufouil C, During E, Düzel E, Galimberti D, Garcia-Ribas G, García-Alberca JM, García-González P, Giedraitis V, Goldhardt O, Graff C, Grünblatt E, Hanon O, Hausner L, Heilmann-Heimbach S, Holstege H, Hort J, Jung YJ, Jürgen D, Kern S, Kuulasmaa T, Lee KH, Lin L, Masullo C, Mecocci P, Mehrabian S, de Mendonça A, Boada M, Mir P, Moebus S, Moreno F, Nacmias B, Nicolas G, Niida S, Nordestgaard BG, Papenberg G, Papma J, Parnetti L, Pasquier F, Pastor P, Peters O, Pijnenburg YAL, Piñol-Ripoll G, Popp J, Porcel LM, Puerta R, Pérez-Tur J, Rainero I, Ramakers I, Real LM, Riedel-Heller S, Rodriguez-Rodriguez E, Ross OA, Royo LJ, Rujescu D, Scarmeas N, Scheltens P, Scherbaum N, Schneider A, Seripa D, Skoog I, Solfrizzi V, Spalletta G, Squassina A, van Swieten J, Sánchez-Valle R, Tan EK, … See abstract for full author list ➔ Le Guen Y, et al. Among authors: solfrizzi v. Proc Natl Acad Sci U S A. 2023 Sep 5;120(36):e2302720120. doi: 10.1073/pnas.2302720120. Epub 2023 Aug 29. Proc Natl Acad Sci U S A. 2023. PMID: 37643212 Free PMC article.
Passive tau-based immunotherapy for tauopathies.
Panza F, Solfrizzi V, Daniele A, Lozupone M. Panza F, et al. Among authors: solfrizzi v. Handb Clin Neurol. 2023;196:611-619. doi: 10.1016/B978-0-323-98817-9.00029-6. Handb Clin Neurol. 2023. PMID: 37620094 Review.
Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies.
Panza F, Dibello V, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Stallone R, Cirillo N, Damiani C, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Lozupone M. Panza F, et al. Among authors: solfrizzi v. Expert Opin Investig Drugs. 2023 Jul-Dec;32(7):625-634. doi: 10.1080/13543784.2023.2233892. Epub 2023 Jul 10. Expert Opin Investig Drugs. 2023. PMID: 37405389 Review.
261 results